| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | FLT3 RARB GATA4 HIPK2 PPP1R13B BCOR ADD1 PER2 TLE1 TLE4 MKX SMARCA4 HES1 PAX2 SLC30A9 LEF1 MED13 CRTC2 | 1.42e-08 | 753 | 95 | 18 | GO:0008134 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | FLT3 RARB GATA4 HIPK2 BCOR ADD1 PER2 TLE1 TLE4 MKX SMARCA4 HES1 SLC30A9 LEF1 MED13 CRTC2 | 1.45e-08 | 582 | 95 | 16 | GO:0140297 |
| GeneOntologyMolecularFunction | transcription coregulator activity | CASP8AP2 HIPK2 ZMIZ1 BCOR SS18 PER2 TLE1 TLE2 TLE3 TLE4 SMARCA2 SMARCA4 SLC30A9 MED13 | 4.20e-07 | 562 | 95 | 14 | GO:0003712 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | FLT3 RARB GATA4 HIPK2 ADD1 PER2 MKX SMARCA4 HES1 SLC30A9 LEF1 MED13 | 6.73e-07 | 417 | 95 | 12 | GO:0061629 |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.37e-05 | 229 | 95 | 8 | GO:0003714 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.11e-05 | 187 | 95 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | chromatin binding | GATA4 EGR1 SUPT5H GLI2 TLE1 TLE4 SMARCA2 SMARCA4 HES1 TBR1 SLC30A9 LEF1 CRTC2 | 4.68e-05 | 739 | 95 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 9.93e-05 | 303 | 95 | 8 | GO:0003713 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | FCRL2 CASP8AP2 HIPK2 ZMIZ1 BCOR SS18 PER2 ABI2 TLE1 TLE2 TLE3 TLE4 SMARCA2 SMARCA4 SLC30A9 MED13 | 1.09e-04 | 1160 | 95 | 16 | GO:0030674 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | HIVEP1 RARB GATA4 BCOR OTP USF3 PER2 EGR1 UBP1 GLI2 MKX SMARCA4 HES1 PAX2 TBR1 LEF1 MYBL2 SMAD9 | 1.58e-04 | 1459 | 95 | 18 | GO:0000977 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 2.04e-04 | 61 | 95 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 5.51e-04 | 140 | 95 | 5 | GO:0001221 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | FCRL2 CASP8AP2 HIPK2 ZMIZ1 BCOR SS18 PER2 ABI2 TLE1 TLE2 TLE3 TLE4 SMARCA2 SMARCA4 SLC30A9 MED13 | 6.28e-04 | 1356 | 95 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | HIVEP1 RARB GATA4 PER2 EGR1 UBP1 GLI2 MKX SMARCA4 HES1 PAX2 TBR1 LEF1 MYBL2 SMAD9 | 7.58e-04 | 1244 | 95 | 15 | GO:0000978 |
| GeneOntologyMolecularFunction | SMAD binding | 7.58e-04 | 86 | 95 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | HIVEP1 RARB GATA4 PER2 EGR1 UBP1 GLI2 MKX SMARCA4 HES1 PAX2 TBR1 LEF1 MYBL2 SMAD9 | 9.43e-04 | 1271 | 95 | 15 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | HIVEP1 RARB GATA4 OTP USF3 EGR1 UBP1 GLI2 MKX HES1 PAX2 TBR1 LEF1 FOXG1 MYBL2 SMAD9 | 9.68e-04 | 1412 | 95 | 16 | GO:0000981 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.50e-03 | 566 | 95 | 9 | GO:0001216 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | CASP8AP2 HIVEP1 RARB GATA4 HIPK2 BCOR NEDD4 OTP PER2 EGR1 SUPT5H GLI2 TLE1 TLE2 TLE3 TLE4 MKX SMARCA2 SMARCA4 HES1 PAX2 MAGEC1 TBR1 LEF1 FOXG1 | 4.32e-09 | 1399 | 97 | 25 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | CASP8AP2 HIVEP1 RARB GATA4 HIPK2 BCOR NEDD4 OTP PER2 EGR1 SUPT5H GLI2 TLE1 TLE2 TLE3 TLE4 MKX SMARCA2 SMARCA4 HES1 PAX2 MAGEC1 TBR1 LEF1 FOXG1 | 5.29e-09 | 1413 | 97 | 25 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | HIVEP1 RARB GATA4 HIPK2 BCOR NEDD4 OTP PER2 EGR1 SUPT5H GLI2 TLE1 TLE4 MKX SMARCA2 SMARCA4 HES1 PAX2 MAGEC1 LEF1 FOXG1 | 1.49e-08 | 1053 | 97 | 21 | GO:0000122 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | RARB GATA4 HIPK2 ZMIZ1 BCOR FREM1 NEDD4 ENAM ABI2 GLI2 TLE1 TLE2 TLE3 ERRFI1 SMARCA4 HES1 PAX2 TBR1 CSMD1 USH2A LEF1 FOXG1 | 7.69e-08 | 1269 | 97 | 22 | GO:0009887 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | HIVEP1 RARB GATA4 HIPK2 ZMIZ1 SS18 USF3 EGR1 SUPT5H UBP1 GLI2 MKX SMARCA2 SMARCA4 HES1 PAX2 TBR1 SLC30A9 LEF1 MED13 CRTC2 MYBL2 SMAD9 | 8.52e-08 | 1390 | 97 | 23 | GO:0045944 |
| GeneOntologyBiologicalProcess | forebrain generation of neurons | 6.11e-07 | 65 | 97 | 6 | GO:0021872 | |
| GeneOntologyBiologicalProcess | forebrain neuron differentiation | 4.98e-06 | 53 | 97 | 5 | GO:0021879 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | ARHGAP32 FRYL SS18 PICALM ADD1 CYFIP2 NEDD4 ENAM ATXN2 ABI2 GLI2 SMARCA4 KIAA1755 HES1 PAX2 TBR1 LEF1 FOXG1 | 1.01e-05 | 1194 | 97 | 18 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | ARHGAP32 ZMIZ1 PICALM ADD1 BNC1 OTP GLI2 SMARCA2 SMARCA4 HES1 LEF1 FOXG1 | 3.09e-05 | 614 | 97 | 12 | GO:0010720 |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | FLT3 GATA4 HIPK2 ZMIZ1 SS18 BIRC6 BNC1 OTP EGR1 TJP1 GLI2 SMARCA2 SMARCA4 HES1 PAX2 LEF1 FOXG1 | 3.65e-05 | 1190 | 97 | 17 | GO:0008284 |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 4.05e-05 | 197 | 97 | 7 | GO:0030509 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | RARB GATA4 ADD1 ENAM OTP ABI2 TJP1 GLI2 ERRFI1 SMARCA4 HES1 PAX2 USH2A LEF1 | 5.48e-05 | 870 | 97 | 14 | GO:0030855 |
| GeneOntologyBiologicalProcess | hindbrain development | 5.72e-05 | 208 | 97 | 7 | GO:0030902 | |
| GeneOntologyBiologicalProcess | pyramidal neuron migration to cerebral cortex | 6.55e-05 | 3 | 97 | 2 | GO:0021852 | |
| GeneOntologyBiologicalProcess | response to BMP | 7.04e-05 | 215 | 97 | 7 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 7.04e-05 | 215 | 97 | 7 | GO:0071773 | |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 7.46e-05 | 217 | 97 | 7 | GO:0021953 | |
| GeneOntologyBiologicalProcess | cell fate determination | 8.97e-05 | 50 | 97 | 4 | GO:0001709 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | FLT3 HIPK2 PICALM HEPH ADD1 PER2 EGR1 ATXN2 TJP1 TLE3 ERRFI1 SMARCA2 SMARCA4 MERTK USH2A | 1.03e-04 | 1043 | 97 | 15 | GO:0048871 |
| GeneOntologyBiologicalProcess | anatomical structure regression | 1.08e-04 | 20 | 97 | 3 | GO:0060033 | |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell differentiation | 1.25e-04 | 164 | 97 | 6 | GO:0002065 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | FLT3 RARB HUWE1 BCOR SS18 USF3 ATXN2 GLI2 MKX SMARCA2 SMARCA4 HES1 PAX2 USH2A LEF1 FOXG1 | 1.72e-04 | 1220 | 97 | 16 | GO:0051093 |
| GeneOntologyBiologicalProcess | regulation of DNA binding | 2.11e-04 | 115 | 97 | 5 | GO:0051101 | |
| GeneOntologyBiologicalProcess | oviduct epithelium development | 2.17e-04 | 5 | 97 | 2 | GO:0035846 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | FLT3 ZMIZ1 DCLRE1C EGR1 GLI2 SMARCA2 SMARCA4 MERTK LEF1 IL9R | 2.18e-04 | 537 | 97 | 10 | GO:0030098 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 2.52e-04 | 351 | 97 | 8 | GO:0048562 | |
| GeneOntologyBiologicalProcess | negative regulation of chondrocyte differentiation | 2.72e-04 | 27 | 97 | 3 | GO:0032331 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 3.08e-04 | 561 | 97 | 10 | GO:0048568 | |
| GeneOntologyBiologicalProcess | radial glia-guided pyramidal neuron migration | 3.24e-04 | 6 | 97 | 2 | GO:0140650 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 3.24e-04 | 6 | 97 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | circulatory system development | ADAM19 RARB GATA4 HIPK2 ZMIZ1 BCOR ADD1 NEDD4 EGR1 TJP1 UBP1 GLI2 ERRFI1 SMARCA2 SMARCA4 HES1 LEF1 | 3.72e-04 | 1442 | 97 | 17 | GO:0072359 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 3.86e-04 | 202 | 97 | 6 | GO:0141193 | |
| GeneOntologyBiologicalProcess | chondrocyte proliferation | 4.12e-04 | 31 | 97 | 3 | GO:0035988 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | FLT3 HIVEP1 GATA4 HIPK2 ZMIZ1 LCP2 SS18 CYFIP2 NEDD4 EGR1 ERRFI1 HES1 MERTK LEF1 SMAD9 | 4.14e-04 | 1186 | 97 | 15 | GO:0007167 |
| GeneOntologyBiologicalProcess | metanephric nephron tubule morphogenesis | 4.53e-04 | 7 | 97 | 2 | GO:0072282 | |
| GeneOntologyBiologicalProcess | oviduct development | 4.53e-04 | 7 | 97 | 2 | GO:0060066 | |
| GeneOntologyBiologicalProcess | forebrain development | 4.96e-04 | 489 | 97 | 9 | GO:0030900 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 4.96e-04 | 596 | 97 | 10 | GO:0001701 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 4.99e-04 | 389 | 97 | 8 | GO:0022409 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 5.02e-04 | 78 | 97 | 4 | GO:2000036 | |
| GeneOntologyBiologicalProcess | animal organ formation | 5.02e-04 | 78 | 97 | 4 | GO:0048645 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 5.57e-04 | 605 | 97 | 10 | GO:0071407 | |
| GeneOntologyBiologicalProcess | regulation of binding | 5.61e-04 | 396 | 97 | 8 | GO:0051098 | |
| GeneOntologyBiologicalProcess | hemopoiesis | FLT3 HIPK2 ZMIZ1 PICALM HEPH ADD1 DCLRE1C EGR1 GLI2 SMARCA2 SMARCA4 HES1 MERTK LEF1 IL9R | 5.70e-04 | 1223 | 97 | 15 | GO:0030097 |
| GeneOntologyBiologicalProcess | regulation of cell development | ARHGAP32 FLT3 ZMIZ1 PICALM ADD1 BNC1 OTP PER2 GLI2 SMARCA2 SMARCA4 HES1 LEF1 FOXG1 | 5.89e-04 | 1095 | 97 | 14 | GO:0060284 |
| GeneOntologyBiologicalProcess | embryonic digestive tract development | 5.92e-04 | 35 | 97 | 3 | GO:0048566 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 5.96e-04 | 144 | 97 | 5 | GO:0045582 | |
| GeneOntologyBiologicalProcess | vasculature development | GATA4 HIPK2 ZMIZ1 ADD1 NEDD4 EGR1 TJP1 UBP1 ERRFI1 SMARCA2 SMARCA4 HES1 LEF1 | 6.02e-04 | 969 | 97 | 13 | GO:0001944 |
| GeneOntologyBiologicalProcess | sensory organ development | RARB HIPK2 ABI2 GLI2 SMARCA4 HES1 PAX2 MERTK USH2A LEF1 FOXG1 | 6.34e-04 | 730 | 97 | 11 | GO:0007423 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | FLT3 HIVEP1 GATA4 HIPK2 ZMIZ1 CYFIP2 NEDD4 EGR1 HES1 PAX2 LEF1 SMAD9 | 6.34e-04 | 850 | 97 | 12 | GO:0071363 |
| GeneOntologyBiologicalProcess | negative regulation of cartilage development | 6.43e-04 | 36 | 97 | 3 | GO:0061037 | |
| GeneOntologyBiologicalProcess | brain development | RARB ZMIZ1 OTP ATXN2 GLI2 SMARCA4 HES1 PAX2 TBR1 LEF1 FOXG1 SMAD9 | 6.96e-04 | 859 | 97 | 12 | GO:0007420 |
| GeneOntologyBiologicalProcess | embryonic eye morphogenesis | 7.55e-04 | 38 | 97 | 3 | GO:0048048 | |
| GeneOntologyBiologicalProcess | metanephric nephron development | 7.55e-04 | 38 | 97 | 3 | GO:0072210 | |
| GeneOntologyBiologicalProcess | forebrain radial glial cell differentiation | 7.71e-04 | 9 | 97 | 2 | GO:0021861 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ARHGAP32 PICALM CYFIP2 NEDD4 ABI2 GLI2 KIAA1755 HES1 PAX2 TBR1 FOXG1 | 7.74e-04 | 748 | 97 | 11 | GO:0048667 |
| GeneOntologyBiologicalProcess | negative regulation of canonical Wnt signaling pathway | 8.07e-04 | 154 | 97 | 5 | GO:0090090 | |
| GeneOntologyBiologicalProcess | pattern specification process | 8.34e-04 | 526 | 97 | 9 | GO:0007389 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | FLT3 ZMIZ1 DCLRE1C EGR1 GLI2 SMARCA2 SMARCA4 MERTK LEF1 IL9R | 8.58e-04 | 640 | 97 | 10 | GO:1903131 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | ARHGAP32 ZMIZ1 PICALM ADD1 BNC1 OTP GLI2 SMARCA2 SMARCA4 HES1 PAX2 LEF1 FOXG1 SMAD9 | 8.81e-04 | 1141 | 97 | 14 | GO:0045597 |
| GeneOntologyBiologicalProcess | response to growth factor | FLT3 HIVEP1 GATA4 HIPK2 ZMIZ1 CYFIP2 NEDD4 EGR1 HES1 PAX2 LEF1 SMAD9 | 8.84e-04 | 883 | 97 | 12 | GO:0070848 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 8.93e-04 | 237 | 97 | 6 | GO:0019827 | |
| GeneOntologyBiologicalProcess | metanephric tubule morphogenesis | 9.61e-04 | 10 | 97 | 2 | GO:0072173 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 9.95e-04 | 242 | 97 | 6 | GO:0098727 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 1.01e-03 | 162 | 97 | 5 | GO:0045621 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 1.01e-03 | 94 | 97 | 4 | GO:0003151 | |
| GeneOntologyBiologicalProcess | cartilage development | 1.02e-03 | 243 | 97 | 6 | GO:0051216 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 1.04e-03 | 244 | 97 | 6 | GO:0009755 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 1.04e-03 | 244 | 97 | 6 | GO:0006006 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.09e-03 | 338 | 97 | 7 | GO:0045165 | |
| GeneOntologyBiologicalProcess | developmental growth | ARHGAP32 FLT3 RARB CACNA2D2 GATA4 ZMIZ1 PICALM ADD1 CYFIP2 ATXN2 GLI2 SMARCA4 | 1.16e-03 | 911 | 97 | 12 | GO:0048589 |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion mediated by cadherin | 1.17e-03 | 11 | 97 | 2 | GO:2000049 | |
| GeneOntologyBiologicalProcess | connective tissue development | 1.18e-03 | 343 | 97 | 7 | GO:0061448 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.19e-03 | 445 | 97 | 8 | GO:0141091 | |
| GeneOntologyBiologicalProcess | pituitary gland development | 1.24e-03 | 45 | 97 | 3 | GO:0021983 | |
| GeneOntologyBiologicalProcess | homeostasis of number of cells | 1.25e-03 | 448 | 97 | 8 | GO:0048872 | |
| GeneOntologyBiologicalProcess | head development | RARB ZMIZ1 OTP ATXN2 GLI2 SMARCA4 HES1 PAX2 TBR1 LEF1 FOXG1 SMAD9 | 1.25e-03 | 919 | 97 | 12 | GO:0060322 |
| GeneOntologyBiologicalProcess | positive regulation of binding | 1.25e-03 | 170 | 97 | 5 | GO:0051099 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ARHGAP32 PICALM CYFIP2 NEDD4 ATXN2 ABI2 GLI2 KIAA1755 PAX2 TBR1 FOXG1 | 1.36e-03 | 802 | 97 | 11 | GO:0048812 |
| GeneOntologyBiologicalProcess | progesterone receptor signaling pathway | 1.40e-03 | 12 | 97 | 2 | GO:0050847 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 3.02e-07 | 13 | 97 | 4 | GO:1990907 | |
| GeneOntologyCellularComponent | npBAF complex | 3.40e-05 | 14 | 97 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 3.40e-05 | 14 | 97 | 3 | GO:0140288 | |
| GeneOntologyCellularComponent | transcription regulator complex | 9.98e-05 | 596 | 97 | 11 | GO:0005667 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RANBP2 GATA4 HIPK2 BCOR SS18 KHDC4 PER2 SUPT5H TLE1 TLE3 TLE4 SMARCA2 SMARCA4 LEF1 MED13 MYBL2 SMAD9 | 1.85e-04 | 1377 | 97 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 2.77e-04 | 272 | 97 | 7 | GO:0090575 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 3.59e-04 | 30 | 97 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | chromatin | RARB GATA4 ZMIZ1 SS18 NEDD4 OTP EGR1 UBP1 MKX SMARCA2 SMARCA4 HES1 PAX2 TBR1 LEF1 FOXG1 SMAD9 | 4.31e-04 | 1480 | 97 | 17 | GO:0000785 |
| GeneOntologyCellularComponent | bBAF complex | 9.36e-04 | 10 | 97 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | SCAR complex | 1.36e-03 | 12 | 97 | 2 | GO:0031209 | |
| Domain | Groucho_enhance | 3.26e-09 | 5 | 96 | 4 | IPR009146 | |
| Domain | TLE_N | 3.26e-09 | 5 | 96 | 4 | PF03920 | |
| Domain | Groucho/TLE_N | 3.26e-09 | 5 | 96 | 4 | IPR005617 | |
| Domain | SnAC | 2.61e-05 | 2 | 96 | 2 | SM01314 | |
| Domain | SM_dom_ATX | 2.61e-05 | 2 | 96 | 2 | IPR025852 | |
| Domain | Gln-Leu-Gln_QLQ | 2.61e-05 | 2 | 96 | 2 | IPR014978 | |
| Domain | SnAC | 2.61e-05 | 2 | 96 | 2 | IPR029295 | |
| Domain | SnAC | 2.61e-05 | 2 | 96 | 2 | PF14619 | |
| Domain | QLQ | 2.61e-05 | 2 | 96 | 2 | SM00951 | |
| Domain | LsmAD | 2.61e-05 | 2 | 96 | 2 | PF06741 | |
| Domain | LsmAD_domain | 2.61e-05 | 2 | 96 | 2 | IPR009604 | |
| Domain | QLQ | 2.61e-05 | 2 | 96 | 2 | PS51666 | |
| Domain | SM-ATX | 2.61e-05 | 2 | 96 | 2 | PF14438 | |
| Domain | LsmAD | 2.61e-05 | 2 | 96 | 2 | SM01272 | |
| Domain | QLQ | 2.61e-05 | 2 | 96 | 2 | PF08880 | |
| Domain | Cu-oxidase | 7.82e-05 | 3 | 96 | 2 | PF00394 | |
| Domain | Cu-oxidase | 7.82e-05 | 3 | 96 | 2 | IPR001117 | |
| Domain | HSA | 1.56e-04 | 4 | 96 | 2 | SM00573 | |
| Domain | Cu-oxidase_2 | 1.56e-04 | 4 | 96 | 2 | IPR011706 | |
| Domain | HSA | 1.56e-04 | 4 | 96 | 2 | PS51204 | |
| Domain | HSA_dom | 1.56e-04 | 4 | 96 | 2 | IPR014012 | |
| Domain | HSA | 1.56e-04 | 4 | 96 | 2 | PF07529 | |
| Domain | Cu-oxidase_2 | 1.56e-04 | 4 | 96 | 2 | PF07731 | |
| Domain | Cu_oxidase_CS | 2.59e-04 | 5 | 96 | 2 | IPR033138 | |
| Domain | Cu-oxidase_3 | 2.59e-04 | 5 | 96 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 2.59e-04 | 5 | 96 | 2 | PS00079 | |
| Domain | Cu-oxidase_3 | 2.59e-04 | 5 | 96 | 2 | PF07732 | |
| Domain | BRK | 3.87e-04 | 6 | 96 | 2 | SM00592 | |
| Domain | BRK_domain | 3.87e-04 | 6 | 96 | 2 | IPR006576 | |
| Domain | BRK | 3.87e-04 | 6 | 96 | 2 | PF07533 | |
| Domain | Cu_oxidase_Cu_BS | 3.87e-04 | 6 | 96 | 2 | IPR002355 | |
| Domain | Prefoldin | 5.16e-04 | 72 | 96 | 4 | IPR009053 | |
| Domain | SH3 | 8.71e-04 | 216 | 96 | 6 | SM00326 | |
| Domain | SH3 | 8.71e-04 | 216 | 96 | 6 | PS50002 | |
| Domain | PAM2 | 9.19e-04 | 9 | 96 | 2 | PF07145 | |
| Domain | Ataxin-2_C | 9.19e-04 | 9 | 96 | 2 | IPR009818 | |
| Domain | SH3_domain | 9.58e-04 | 220 | 96 | 6 | IPR001452 | |
| Domain | - | 2.29e-03 | 14 | 96 | 2 | 2.60.40.420 | |
| Domain | Cupredoxin | 5.65e-03 | 22 | 96 | 2 | IPR008972 | |
| Domain | GUANYLATE_KINASE_2 | 6.17e-03 | 23 | 96 | 2 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 6.17e-03 | 23 | 96 | 2 | PS00856 | |
| Domain | UIM | 6.70e-03 | 24 | 96 | 2 | PS50330 | |
| Domain | UIM_dom | 7.26e-03 | 25 | 96 | 2 | IPR003903 | |
| Domain | - | 7.44e-03 | 333 | 96 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 7.65e-03 | 335 | 96 | 6 | IPR015943 | |
| Domain | Guanylate_kin | 7.84e-03 | 26 | 96 | 2 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 7.84e-03 | 26 | 96 | 2 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 7.84e-03 | 26 | 96 | 2 | IPR008144 | |
| Domain | Bromodomain_CS | 7.84e-03 | 26 | 96 | 2 | IPR018359 | |
| Domain | - | 7.84e-03 | 26 | 96 | 2 | 1.25.40.90 | |
| Domain | GuKc | 7.84e-03 | 26 | 96 | 2 | SM00072 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 8.00e-10 | 10 | 73 | 5 | MM15156 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.32e-09 | 26 | 73 | 6 | MM14793 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 6.26e-09 | 14 | 73 | 5 | M27402 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 5.85e-07 | 32 | 73 | 5 | MM14975 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 2.37e-06 | 42 | 73 | 5 | M27272 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.67e-06 | 48 | 73 | 5 | M611 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 7.37e-06 | 91 | 73 | 6 | M27101 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.95e-05 | 74 | 73 | 5 | M616 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 5.42e-05 | 79 | 73 | 5 | MM14754 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 5.76e-05 | 80 | 73 | 5 | M223 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 6.38e-05 | 42 | 73 | 4 | M48237 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 7.70e-05 | 85 | 73 | 5 | M27079 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.65e-04 | 158 | 73 | 6 | MM14791 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 2.59e-04 | 60 | 73 | 4 | M40048 | |
| Pathway | WP_REGULATION_OF_CARDIAC_HYPERTROPHY_BY_MIR208 | 5.46e-04 | 7 | 73 | 2 | MM15860 | |
| Pubmed | 5.93e-11 | 4 | 98 | 4 | 8645603 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | HIVEP1 RARB GATA4 BNC1 OTP USF3 EGR1 UBP1 GLI2 MKX HES1 PAX2 TBR1 SLC30A9 LEF1 FOXG1 MYBL2 SMAD9 | 7.80e-11 | 908 | 98 | 18 | 19274049 |
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 1.25e-10 | 12 | 98 | 5 | 11266540 | |
| Pubmed | 2.96e-10 | 5 | 98 | 4 | 1303260 | ||
| Pubmed | 2.96e-10 | 5 | 98 | 4 | 8365415 | ||
| Pubmed | 2.96e-10 | 5 | 98 | 4 | 11238932 | ||
| Pubmed | 4.70e-10 | 15 | 98 | 5 | 9291577 | ||
| Pubmed | 8.85e-10 | 6 | 98 | 4 | 8573724 | ||
| Pubmed | 8.85e-10 | 6 | 98 | 4 | 8892234 | ||
| Pubmed | A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression. | 2.06e-09 | 7 | 98 | 4 | 24024827 | |
| Pubmed | 2.06e-09 | 7 | 98 | 4 | 16314515 | ||
| Pubmed | ARHGAP32 HIVEP1 GATA4 HIPK2 PPP1R13B ZMIZ1 BCOR SS18 DCAF5 ATXN2 GLI2 TLE1 TLE3 TLE4 SMARCA2 SMARCA4 DLAT PAX2 TBR1 MYBL2 | 2.65e-09 | 1429 | 98 | 20 | 35140242 | |
| Pubmed | A comparison of Notch, Hes and Grg expression during murine embryonic and post-natal development. | 4.11e-09 | 8 | 98 | 4 | 10512199 | |
| Pubmed | Nolz1 promotes striatal neurogenesis through the regulation of retinoic acid signaling. | 4.11e-09 | 8 | 98 | 4 | 20735826 | |
| Pubmed | 4.11e-09 | 8 | 98 | 4 | 16002402 | ||
| Pubmed | 1.23e-08 | 10 | 98 | 4 | 30571765 | ||
| Pubmed | HIVEP1 RARB BIRC6 OTP PER2 GLI2 MKX SMARCA2 SMARCA4 PAX2 LEF1 FOXG1 MYBL2 SMAD9 | 1.27e-08 | 709 | 98 | 14 | 22988430 | |
| Pubmed | Chromatin regulation by BAF170 controls cerebral cortical size and thickness. | 1.50e-08 | 28 | 98 | 5 | 23643363 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 1.93e-08 | 11 | 98 | 4 | 15499562 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 8808280 | ||
| Pubmed | Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity. | 2.17e-08 | 3 | 98 | 3 | 30045946 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 14603256 | ||
| Pubmed | CASP8AP2 RANBP2 HIVEP1 ZMIZ1 HUWE1 BCOR BIRC6 TLE1 TLE3 TLE4 MYBL2 | 2.91e-08 | 418 | 98 | 11 | 34709266 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L RANBP2 HIVEP1 HUWE1 BCOR ADD1 TLE3 TLE4 SMARCA2 SMARCA4 RIPOR1 MN1 MED13 MYBL2 | 3.78e-08 | 774 | 98 | 14 | 15302935 |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 22735158 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | ATXN2L CASP8AP2 RANBP2 QPCTL BCOR ATXN2 SUPT5H TLE1 TLE4 USP32 HES1 MERTK LEF1 MED13 FOXG1 | 4.73e-08 | 922 | 98 | 15 | 27609421 |
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 17202186 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | RANBP2 HIVEP1 GATA4 ZMIZ1 BCOR TLE1 TLE3 TLE4 SMARCA2 SMARCA4 | 6.15e-08 | 351 | 98 | 10 | 38297188 |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 9874198 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 15768032 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 11231080 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 11290324 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MON2 MPP1 ATXN2L CASP8AP2 STAM2 HIVEP1 HIPK2 PPP1R13B HUWE1 BCOR SUPT5H MYBL2 | 1.06e-07 | 588 | 98 | 12 | 38580884 |
| Pubmed | CASP8AP2 ARHGAP32 RANBP2 HIVEP1 HIPK2 PPP1R13B LCP2 SS18 USF3 EGR1 ERRFI1 | 1.33e-07 | 486 | 98 | 11 | 20936779 | |
| Pubmed | 1.36e-07 | 83 | 98 | 6 | 28794006 | ||
| Pubmed | 1.76e-07 | 18 | 98 | 4 | 33658226 | ||
| Pubmed | 1.76e-07 | 18 | 98 | 4 | 11731482 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | HIVEP1 QPCTL BCOR PDE12 SUPT5H UBP1 TLE1 TLE3 SMARCA2 SMARCA4 | 1.97e-07 | 398 | 98 | 10 | 35016035 |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 24270405 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 18611861 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 8989517 | ||
| Pubmed | MON2 STAM2 ARHGAP32 RANBP2 PPP1R13B HUWE1 BCOR BIRC6 CYFIP2 ATXN2 ABI2 TJP1 SUPT5H TLE3 LPP | 2.49e-07 | 1049 | 98 | 15 | 27880917 | |
| Pubmed | 2.77e-07 | 20 | 98 | 4 | 16920270 | ||
| Pubmed | Expression of Groucho/TLE proteins during pancreas development. | 6.03e-07 | 24 | 98 | 4 | 18778483 | |
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 17074803 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TUT4 CACNA2D2 HIPK2 FRYL ZMIZ1 HUWE1 USF3 FAM168A ATXN2 TJP1 GLI2 TLE3 LPP SMARCA2 RIPOR1 CSMD1 ARHGAP8 | 8.51e-07 | 1489 | 98 | 17 | 28611215 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | RANBP2 GATA4 HUWE1 CYFIP2 ABI2 UBP1 TLE1 TLE3 TLE4 SMARCA4 FOXG1 MYBL2 SMAD9 | 8.81e-07 | 857 | 98 | 13 | 25609649 |
| Pubmed | 9.42e-07 | 267 | 98 | 8 | 33417871 | ||
| Pubmed | 9.68e-07 | 268 | 98 | 8 | 33640491 | ||
| Pubmed | 9.90e-07 | 27 | 98 | 4 | 33760820 | ||
| Pubmed | MON2 MPP1 ATXN2L TUT4 HUWE1 BIRC6 ADD1 TJP1 TLE1 LPP SMARCA4 MYBL2 | 1.09e-06 | 733 | 98 | 12 | 34672954 | |
| Pubmed | 1.15e-06 | 28 | 98 | 4 | 22232070 | ||
| Pubmed | 1.16e-06 | 65 | 98 | 5 | 26655900 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 26986003 | ||
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 1.20e-06 | 8 | 98 | 3 | 28296634 | |
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 25896202 | ||
| Pubmed | 1.76e-06 | 31 | 98 | 4 | 27321927 | ||
| Pubmed | 1.93e-06 | 130 | 98 | 6 | 19386638 | ||
| Pubmed | PAR3 restricts the expansion of neural precursor cells by regulating hedgehog signaling. | 2.28e-06 | 33 | 98 | 4 | 36218069 | |
| Pubmed | 2.30e-06 | 134 | 98 | 6 | 19030180 | ||
| Pubmed | 2.57e-06 | 10 | 98 | 3 | 10781944 | ||
| Pubmed | ARHGAP32 RANBP2 HUWE1 BCOR PICALM ADD1 CYFIP2 NEDD4 ATXN2 ABI2 TJP1 SMARCA4 FOXG1 | 3.18e-06 | 963 | 98 | 13 | 28671696 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 3.30e-06 | 544 | 98 | 10 | 28473536 | |
| Pubmed | 3.52e-06 | 11 | 98 | 3 | 34184026 | ||
| Pubmed | 3.52e-06 | 11 | 98 | 3 | 22439931 | ||
| Pubmed | Targeting HIV transcription: the quest for a functional cure. | 3.52e-06 | 11 | 98 | 3 | 25731772 | |
| Pubmed | Baf60c is a component of the neural progenitor-specific BAF complex in developing retina. | 4.69e-06 | 12 | 98 | 3 | 18816825 | |
| Pubmed | Congenital diaphragmatic hernia: comparison of animal models and relevance to the human situation. | 4.69e-06 | 12 | 98 | 3 | 19325248 | |
| Pubmed | 4.69e-06 | 12 | 98 | 3 | 11734557 | ||
| Pubmed | 4.69e-06 | 12 | 98 | 3 | 24695699 | ||
| Pubmed | Genetic control of brain morphogenesis through Otx gene dosage requirement. | 6.08e-06 | 13 | 98 | 3 | 9342056 | |
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 7.72e-06 | 14 | 98 | 3 | 36289231 | |
| Pubmed | 7.72e-06 | 14 | 98 | 3 | 30510198 | ||
| Pubmed | 7.72e-06 | 14 | 98 | 3 | 33075808 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19765320 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 25673149 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 8670841 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23163725 | ||
| Pubmed | The Circadian Protein Period2 Suppresses mTORC1 Activity via Recruiting Tsc1 to mTORC1 Complex. | 7.86e-06 | 2 | 98 | 2 | 30527742 | |
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 7.86e-06 | 2 | 98 | 2 | 23076393 | |
| Pubmed | Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML. | 7.86e-06 | 2 | 98 | 2 | 33974912 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 15576411 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 15240517 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 7.86e-06 | 2 | 98 | 2 | 33027072 | |
| Pubmed | Gro/TLE enables embryonic stem cell differentiation by repressing pluripotent gene expression. | 7.86e-06 | 2 | 98 | 2 | 25446531 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23872584 | ||
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 7.86e-06 | 2 | 98 | 2 | 23088494 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 20333683 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 34812766 | ||
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 7.86e-06 | 2 | 98 | 2 | 30478150 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 9572356 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 34680978 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 39062631 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 25762638 | ||
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 7.86e-06 | 2 | 98 | 2 | 25808524 | |
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 7.86e-06 | 2 | 98 | 2 | 19144648 | |
| Pubmed | TLE4 acts as a corepressor of Hes1 to inhibit inflammatory responses in macrophages. | 7.86e-06 | 2 | 98 | 2 | 29869113 | |
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 7.86e-06 | 2 | 98 | 2 | 29391527 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24676634 | ||
| Interaction | TLE3 interactions | HIVEP1 ZMIZ1 BCOR KHDC4 EGR1 GLI2 TLE1 TLE2 TLE3 TLE4 SMARCA4 PAX2 TBR1 FOXG1 CRTC2 MYBL2 | 3.15e-11 | 376 | 97 | 16 | int:TLE3 |
| Interaction | TBXT interactions | 4.74e-09 | 116 | 97 | 9 | int:TBXT | |
| Interaction | ERG interactions | HIVEP1 GATA4 HIPK2 HUWE1 BCOR SS18 NEDD4 TLE1 TLE3 SMARCA2 SMARCA4 | 1.03e-08 | 223 | 97 | 11 | int:ERG |
| Interaction | TBR1 interactions | 7.26e-08 | 113 | 97 | 8 | int:TBR1 | |
| Interaction | TLE1 interactions | 7.95e-08 | 213 | 97 | 10 | int:TLE1 | |
| Interaction | PAX7 interactions | 1.50e-07 | 124 | 97 | 8 | int:PAX7 | |
| Interaction | ARID1B interactions | 1.87e-07 | 177 | 97 | 9 | int:ARID1B | |
| Interaction | SP7 interactions | HIVEP1 ZMIZ1 BCOR SS18 TLE1 TLE3 TLE4 SMARCA2 SMARCA4 TBR1 MYBL2 | 2.42e-07 | 304 | 97 | 11 | int:SP7 |
| Interaction | HDAC1 interactions | CASP8AP2 RANBP2 HIVEP1 RARB GATA4 ZMIZ1 BCOR SS18 BIRC6 XYLT2 GLI2 TLE1 TLE3 TLE4 MKX SMARCA2 SMARCA4 HES1 LEF1 FOXG1 | 2.56e-07 | 1108 | 97 | 20 | int:HDAC1 |
| Interaction | TLE4 interactions | 3.02e-07 | 92 | 97 | 7 | int:TLE4 | |
| Interaction | GCM1 interactions | 9.15e-07 | 68 | 97 | 6 | int:GCM1 | |
| Interaction | EN1 interactions | 1.02e-06 | 110 | 97 | 7 | int:EN1 | |
| Interaction | PAX8 interactions | 1.09e-06 | 111 | 97 | 7 | int:PAX8 | |
| Interaction | NLK interactions | 1.09e-06 | 70 | 97 | 6 | int:NLK | |
| Interaction | KDM1A interactions | CASP8AP2 RANBP2 HIVEP1 GATA4 ZMIZ1 HUWE1 BCOR BIRC6 SUPT5H TLE3 TLE4 SMARCA2 HES1 SAMD3 FOXG1 MYBL2 SMAD9 | 2.30e-06 | 941 | 97 | 17 | int:KDM1A |
| Interaction | RIPPLY2 interactions | 2.30e-06 | 20 | 97 | 4 | int:RIPPLY2 | |
| Interaction | RNF138 interactions | 2.41e-06 | 125 | 97 | 7 | int:RNF138 | |
| Interaction | TBX20 interactions | 2.83e-06 | 21 | 97 | 4 | int:TBX20 | |
| Interaction | PAX9 interactions | 3.13e-06 | 130 | 97 | 7 | int:PAX9 | |
| Interaction | TLE2 interactions | 4.23e-06 | 136 | 97 | 7 | int:TLE2 | |
| Interaction | MYOD1 interactions | 4.44e-06 | 194 | 97 | 8 | int:MYOD1 | |
| Interaction | MFAP4 interactions | 4.89e-06 | 139 | 97 | 7 | int:MFAP4 | |
| Interaction | SRF interactions | 4.89e-06 | 139 | 97 | 7 | int:SRF | |
| Interaction | NCOR2 interactions | 5.19e-06 | 264 | 97 | 9 | int:NCOR2 | |
| Interaction | GATA2 interactions | 5.35e-06 | 199 | 97 | 8 | int:GATA2 | |
| Interaction | NFIB interactions | 5.63e-06 | 142 | 97 | 7 | int:NFIB | |
| Interaction | ARID1A interactions | 7.43e-06 | 276 | 97 | 9 | int:ARID1A | |
| Interaction | ATXN1 interactions | ATXN2L STAM2 ARHGAP32 RANBP2 HIVEP1 HUWE1 BCOR PICALM FAM168A ATXN2 SUPT5H TLE3 TLE4 SMARCA4 DLAT PAX2 TBR1 | 8.60e-06 | 1039 | 97 | 17 | int:ATXN1 |
| Interaction | SMARCD3 interactions | 1.30e-05 | 107 | 97 | 6 | int:SMARCD3 | |
| Interaction | NFIX interactions | 1.40e-05 | 227 | 97 | 8 | int:NFIX | |
| Interaction | LHX4 interactions | 1.56e-05 | 166 | 97 | 7 | int:LHX4 | |
| Interaction | SIX6 interactions | 1.73e-05 | 11 | 97 | 3 | int:SIX6 | |
| Interaction | ETS1 interactions | 2.62e-05 | 121 | 97 | 6 | int:ETS1 | |
| Interaction | MAML1 interactions | 2.70e-05 | 73 | 97 | 5 | int:MAML1 | |
| Interaction | LHX2 interactions | 2.93e-05 | 183 | 97 | 7 | int:LHX2 | |
| Interaction | HLX interactions | 2.95e-05 | 37 | 97 | 4 | int:HLX | |
| Interaction | GATA3 interactions | 3.36e-05 | 187 | 97 | 7 | int:GATA3 | |
| Interaction | NFIA interactions | 3.48e-05 | 188 | 97 | 7 | int:NFIA | |
| Interaction | HNF1B interactions | 3.72e-05 | 190 | 97 | 7 | int:HNF1B | |
| Interaction | KLF5 interactions | 4.39e-05 | 195 | 97 | 7 | int:KLF5 | |
| Interaction | NKX2-5 interactions | 4.74e-05 | 82 | 97 | 5 | int:NKX2-5 | |
| Interaction | SOX7 interactions | 4.74e-05 | 82 | 97 | 5 | int:SOX7 | |
| Interaction | PRDM1 interactions | 5.32e-05 | 84 | 97 | 5 | int:PRDM1 | |
| Interaction | PBX1 interactions | 5.63e-05 | 85 | 97 | 5 | int:PBX1 | |
| Interaction | PAX2 interactions | 5.63e-05 | 85 | 97 | 5 | int:PAX2 | |
| Interaction | FEV interactions | 5.67e-05 | 203 | 97 | 7 | int:FEV | |
| Interaction | SMAD3 interactions | ATXN2L HIVEP1 GATA4 HIPK2 ZMIZ1 NEDD4 SMARCA4 LEF1 FOXG1 SMAD9 | 5.86e-05 | 447 | 97 | 10 | int:SMAD3 |
| Interaction | SS18 interactions | 6.65e-05 | 88 | 97 | 5 | int:SS18 | |
| Interaction | SH3GL2 interactions | 6.65e-05 | 88 | 97 | 5 | int:SH3GL2 | |
| Interaction | PAX6 interactions | 6.83e-05 | 366 | 97 | 9 | int:PAX6 | |
| Interaction | NFIC interactions | 7.01e-05 | 210 | 97 | 7 | int:NFIC | |
| Interaction | FOXI1 interactions | 8.22e-05 | 92 | 97 | 5 | int:FOXI1 | |
| Interaction | ATXN1L interactions | 8.71e-05 | 150 | 97 | 6 | int:ATXN1L | |
| Interaction | CTNNB1 interactions | ATXN2L ARHGAP32 RANBP2 FLT3 PPP1R13B ZMIZ1 HUWE1 CYFIP2 EGR1 TJP1 TLE1 TLE3 SMARCA4 SLC30A9 LEF1 | 9.22e-05 | 1009 | 97 | 15 | int:CTNNB1 |
| Interaction | DPF1 interactions | 9.58e-05 | 95 | 97 | 5 | int:DPF1 | |
| Interaction | SMAD2 interactions | 1.00e-04 | 385 | 97 | 9 | int:SMAD2 | |
| Interaction | PIP5K1A interactions | 1.08e-04 | 156 | 97 | 6 | int:PIP5K1A | |
| Interaction | EP300 interactions | RARB GATA4 HIPK2 PPP1R13B SS18 BIRC6 NEDD4 PDE12 EGR1 SUPT5H TLE3 SMARCA2 SMARCA4 TBR1 LEF1 MN1 CRTC2 MYBL2 | 1.12e-04 | 1401 | 97 | 18 | int:EP300 |
| Interaction | HES6 interactions | 1.14e-04 | 52 | 97 | 4 | int:HES6 | |
| Interaction | ANKRD29 interactions | 1.16e-04 | 20 | 97 | 3 | int:ANKRD29 | |
| Interaction | SIX3 interactions | 1.16e-04 | 20 | 97 | 3 | int:SIX3 | |
| Interaction | KDM6A interactions | 1.33e-04 | 162 | 97 | 6 | int:KDM6A | |
| Interaction | PTPN23 interactions | 1.33e-04 | 162 | 97 | 6 | int:PTPN23 | |
| Interaction | SALL1 interactions | 1.34e-04 | 102 | 97 | 5 | int:SALL1 | |
| Interaction | RIPPLY1 interactions | 1.42e-04 | 55 | 97 | 4 | int:RIPPLY1 | |
| Interaction | KBTBD4 interactions | 1.44e-04 | 316 | 97 | 8 | int:KBTBD4 | |
| Interaction | TPRX2 interactions | 1.53e-04 | 56 | 97 | 4 | int:TPRX2 | |
| Interaction | SMARCA5 interactions | 1.76e-04 | 415 | 97 | 9 | int:SMARCA5 | |
| Interaction | TNIP2 interactions | ATXN2L CASP8AP2 RANBP2 BCOR ATXN2 SUPT5H TLE1 TLE4 USP32 HES1 MERTK LEF1 MED13 FOXG1 | 1.81e-04 | 952 | 97 | 14 | int:TNIP2 |
| Interaction | APH1A interactions | 2.00e-04 | 60 | 97 | 4 | int:APH1A | |
| Interaction | TLX1 interactions | 2.02e-04 | 175 | 97 | 6 | int:TLX1 | |
| Interaction | NUP35 interactions | 2.07e-04 | 424 | 97 | 9 | int:NUP35 | |
| Interaction | RIPPLY3 interactions | 2.08e-04 | 112 | 97 | 5 | int:RIPPLY3 | |
| Interaction | FBRSL1 interactions | 2.13e-04 | 61 | 97 | 4 | int:FBRSL1 | |
| Interaction | FLI1 interactions | 2.27e-04 | 62 | 97 | 4 | int:FLI1 | |
| Interaction | CRX interactions | 2.28e-04 | 254 | 97 | 7 | int:CRX | |
| Interaction | NR3C1 interactions | CASP8AP2 ARHGAP32 HIVEP1 RARB MLEC BCOR SS18 EGR1 UBP1 TLE3 SMARCA2 SMARCA4 DLAT MYBL2 | 2.29e-04 | 974 | 97 | 14 | int:NR3C1 |
| Interaction | ZBTB3 interactions | 2.57e-04 | 64 | 97 | 4 | int:ZBTB3 | |
| Interaction | HES1 interactions | 2.57e-04 | 64 | 97 | 4 | int:HES1 | |
| Interaction | SMARCD2 interactions | 2.58e-04 | 183 | 97 | 6 | int:SMARCD2 | |
| Interaction | LHX3 interactions | 2.73e-04 | 185 | 97 | 6 | int:LHX3 | |
| Interaction | AR interactions | HIVEP1 HIPK2 ZMIZ1 HUWE1 BCOR TJP1 GLI2 TLE1 TLE3 TLE4 SMARCA2 SMARCA4 MED13 FOXG1 | 2.76e-04 | 992 | 97 | 14 | int:AR |
| Interaction | DAZAP2 interactions | 2.81e-04 | 186 | 97 | 6 | int:DAZAP2 | |
| Interaction | TLE5 interactions | 2.86e-04 | 443 | 97 | 9 | int:TLE5 | |
| Interaction | VSX1 interactions | 2.89e-04 | 66 | 97 | 4 | int:VSX1 | |
| Interaction | BRCA1 interactions | ATXN2L FLT3 HIVEP1 PPP1R13B ZMIZ1 HUWE1 PICALM PDE12 DCLRE1C EGR1 SUPT5H TLE4 SMARCA2 SMARCA4 PAX2 USH2A | 2.92e-04 | 1249 | 97 | 16 | int:BRCA1 |
| Interaction | BICRA interactions | 3.06e-04 | 67 | 97 | 4 | int:BICRA | |
| Interaction | BCL7A interactions | 3.21e-04 | 123 | 97 | 5 | int:BCL7A | |
| Interaction | ETV4 interactions | 3.43e-04 | 69 | 97 | 4 | int:ETV4 | |
| Interaction | LEF1 interactions | 3.43e-04 | 69 | 97 | 4 | int:LEF1 | |
| Interaction | NCOR1 interactions | 3.68e-04 | 363 | 97 | 8 | int:NCOR1 | |
| Interaction | HNF4A interactions | 3.68e-04 | 275 | 97 | 7 | int:HNF4A | |
| Interaction | TIA1 interactions | 3.68e-04 | 275 | 97 | 7 | int:TIA1 | |
| Interaction | FOXL1 interactions | 3.72e-04 | 196 | 97 | 6 | int:FOXL1 | |
| Interaction | EGR1 interactions | 4.04e-04 | 72 | 97 | 4 | int:EGR1 | |
| Interaction | POLB interactions | 4.04e-04 | 72 | 97 | 4 | int:POLB | |
| Interaction | E2F1 interactions | 4.14e-04 | 200 | 97 | 6 | int:E2F1 | |
| Interaction | KRT19 interactions | 4.28e-04 | 282 | 97 | 7 | int:KRT19 | |
| Interaction | PROSER1 interactions | 4.41e-04 | 31 | 97 | 3 | int:PROSER1 | |
| Interaction | ISX interactions | 4.41e-04 | 31 | 97 | 3 | int:ISX | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TUT4 HIVEP1 FRYL ZMIZ1 PICALM NEDD4 MGAT5 ATXN2 TLE1 TLE4 SMARCA2 MED13 | 1.58e-07 | 466 | 97 | 12 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 TUT4 HIVEP1 FRYL ZMIZ1 PICALM NEDD4 MGAT5 FAM168A ATXN2 TLE1 TLE4 SMARCA2 MN1 MED13 | 5.80e-07 | 856 | 97 | 15 | M4500 |
| Coexpression | BENPORATH_ES_CORE_NINE_CORRELATED | 1.98e-06 | 100 | 97 | 6 | M14079 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | 2.78e-06 | 506 | 97 | 11 | M253 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | ARHGAP32 FLT3 MLEC ZMIZ1 HUWE1 PER2 ABI2 TLE4 USH2A MN1 SMAD9 | 9.16e-06 | 574 | 97 | 11 | M8215 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | ARHGAP32 FLT3 MLEC ZMIZ1 HUWE1 PER2 ABI2 TLE4 USH2A MN1 SMAD9 | 1.38e-05 | 600 | 97 | 11 | MM1025 |
| Coexpression | RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP | 1.90e-05 | 148 | 97 | 6 | M39016 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ATXN2L RANBP2 TUT4 ADAM19 SLC26A2 FRYL HUWE1 LCP2 ZNF831 BIRC6 PICALM DCAF5 ADD1 CYFIP2 SMARCA2 SAMD3 MED13 | 3.12e-05 | 1492 | 97 | 17 | M40023 |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_DN | 9.36e-05 | 197 | 97 | 6 | M4946 | |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_UP | 9.89e-05 | 199 | 97 | 6 | M5970 | |
| Coexpression | GSE14308_TH2_VS_TH1_UP | 9.89e-05 | 199 | 97 | 6 | M3359 | |
| Coexpression | GSE29949_MICROGLIA_VS_DC_BRAIN_UP | 9.89e-05 | 199 | 97 | 6 | M8399 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN | 1.02e-04 | 200 | 97 | 6 | M8027 | |
| Coexpression | GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP | 1.02e-04 | 200 | 97 | 6 | M8290 | |
| Coexpression | GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP | 1.02e-04 | 200 | 97 | 6 | M5227 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 1.02e-04 | 200 | 97 | 6 | M6056 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.28e-04 | 300 | 97 | 7 | M8702 | |
| Coexpression | LI_WILMS_TUMOR | 1.35e-04 | 27 | 97 | 3 | M10773 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-10 | 190 | 98 | 9 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.12e-08 | 193 | 98 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.93e-07 | 187 | 98 | 7 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 2.10e-06 | 170 | 98 | 6 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 2.41e-06 | 174 | 98 | 6 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 2.41e-06 | 174 | 98 | 6 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 2.74e-06 | 178 | 98 | 6 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | IPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 2.93e-06 | 180 | 98 | 6 | 0f8567aa835d4e3a52f6631ae15216eca18a030c | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-06 | 182 | 98 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-06 | 182 | 98 | 6 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.43e-06 | 185 | 98 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 3.65e-06 | 187 | 98 | 6 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.76e-06 | 188 | 98 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.88e-06 | 189 | 98 | 6 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-06 | 189 | 98 | 6 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 4.00e-06 | 190 | 98 | 6 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.12e-06 | 191 | 98 | 6 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.37e-06 | 193 | 98 | 6 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | Adult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor | 4.37e-06 | 193 | 98 | 6 | 26df0c4c8a2355dd5503fadd07e368eb9a2bf06a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.37e-06 | 193 | 98 | 6 | 1b7d17ef85bbe57adfdf68b728978c4d5521a298 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.37e-06 | 193 | 98 | 6 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.50e-06 | 194 | 98 | 6 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | Adult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor | 4.50e-06 | 194 | 98 | 6 | 5c1dca33f382f37a7deb23e573578343c3b54986 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-06 | 197 | 98 | 6 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.21e-06 | 199 | 98 | 6 | c9e1ac9f0fba23250a5df4052559d18d16df4521 | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 5.21e-06 | 199 | 98 | 6 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-06 | 200 | 98 | 6 | c6c2b39359c65c9444987d02d1c899dff2ad1366 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-06 | 200 | 98 | 6 | 9de4d6ebb7e9bee5d811519eb05913ef30f70786 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-05 | 158 | 98 | 5 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 2.70e-05 | 159 | 98 | 5 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 162 | 98 | 5 | eb2900a250fb3e08e479c727c7d3200cbcf37fbc | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 162 | 98 | 5 | 1ef3084b5766641ec07c6f488c1756239cf3fd61 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-05 | 164 | 98 | 5 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.22e-05 | 165 | 98 | 5 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-05 | 172 | 98 | 5 | 001d2553a0b5dae3269727bda8ef8067deebab0d | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.26e-05 | 175 | 98 | 5 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 4.26e-05 | 175 | 98 | 5 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 4.38e-05 | 176 | 98 | 5 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 4.38e-05 | 176 | 98 | 5 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 176 | 98 | 5 | 3c3b6c02d7acdc1305878ee34e9cbabbf9e87892 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 176 | 98 | 5 | 7c743b7e954c1ebfa289ed529abacb88504112ea | |
| ToppCell | Control-Myeloid-pDC|Control / Disease state, Lineage and Cell class | 4.50e-05 | 177 | 98 | 5 | 3940663bb5b45b2ca9f772550380a516c53e410b | |
| ToppCell | COPD-Myeloid-pDC|COPD / Disease state, Lineage and Cell class | 4.50e-05 | 177 | 98 | 5 | 415aa023195a7f961c09529f65cdcc7bb90eaf5d | |
| ToppCell | Control-Myeloid-pDC|World / Disease state, Lineage and Cell class | 4.62e-05 | 178 | 98 | 5 | 20ef63d925e67ddd5955832312ca8574a6f838a4 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Late_pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.62e-05 | 178 | 98 | 5 | 4e28a8bd5a603518bfe993712ab785308691b5ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.75e-05 | 179 | 98 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 4.75e-05 | 179 | 98 | 5 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 4.87e-05 | 180 | 98 | 5 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 5.00e-05 | 181 | 98 | 5 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.00e-05 | 181 | 98 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 184 | 98 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 184 | 98 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 184 | 98 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-05 | 185 | 98 | 5 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-05 | 185 | 98 | 5 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.69e-05 | 186 | 98 | 5 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.69e-05 | 186 | 98 | 5 | aa576748921a318798b911a611f05319b95e8d5e | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.69e-05 | 186 | 98 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.84e-05 | 187 | 98 | 5 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.84e-05 | 187 | 98 | 5 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.84e-05 | 187 | 98 | 5 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.84e-05 | 187 | 98 | 5 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Late_pro-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.99e-05 | 188 | 98 | 5 | 1f24bb9cac5e74323ef93770442a869a89e07cf1 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 189 | 98 | 5 | 533685a921a65d84107d8d33c43b4fffde019143 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.14e-05 | 189 | 98 | 5 | 886dceacf96e2b6750c146a381da0bf96a2bb15b | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 189 | 98 | 5 | dca56ab02bf0505f9a352ff907edaef30906d854 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.14e-05 | 189 | 98 | 5 | 5f1f4321939877374a8ee13de93f2d1390af8e2e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.30e-05 | 190 | 98 | 5 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.30e-05 | 190 | 98 | 5 | 60bb6aaea9691d07295f61c14d1650f5041a0f9c | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.30e-05 | 190 | 98 | 5 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | facs-Marrow-KLS-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 190 | 98 | 5 | a513c1e7df62c28128c932a68b252ee8f0255172 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 190 | 98 | 5 | 07ea0578ca0561077557203ae660530f53fc4067 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 190 | 98 | 5 | 5b4b3eed7aa798bb7e3c5e968c8dc4144e377a5f | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 190 | 98 | 5 | 8f5e71a0861ee4e8f3ce45e8a7f18fb9d6036a3c | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 190 | 98 | 5 | 84265be128170cbb08d76e824aa108e07da9c3e5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-05 | 190 | 98 | 5 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.45e-05 | 191 | 98 | 5 | 133864ec1e89f97a82c3bb01d2a3c658397fefaf | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.45e-05 | 191 | 98 | 5 | 054fa0493b00149313c243d39cf39a264044f074 | |
| ToppCell | Adult-Immune-T_lymphocyte-D175|Adult / Lineage, Cell type, age group and donor | 6.45e-05 | 191 | 98 | 5 | 0b84fd1dc68146d9f72422b102744d2847f5ecb2 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.45e-05 | 191 | 98 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | (1)_Control_(PBS)|World / Stress and Cell class | 6.45e-05 | 191 | 98 | 5 | b346e13259cb2d506b923ad44b894c21a3eee4c3 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 6.45e-05 | 191 | 98 | 5 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 6.45e-05 | 191 | 98 | 5 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.61e-05 | 192 | 98 | 5 | 92f141d5ac462f652f405efa73ac6ef751f40ea3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-27|World / Primary Cells by Cluster | 6.61e-05 | 192 | 98 | 5 | cf989f26c0ebdc0cd12e1e41958f063e4fa3e468 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.61e-05 | 192 | 98 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.61e-05 | 192 | 98 | 5 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 192 | 98 | 5 | 03dcd9405d3d76fc7455066ba5d83c09cd17072d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.61e-05 | 192 | 98 | 5 | 03acd4a26b986e34eee608747347791122f1aa52 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.61e-05 | 192 | 98 | 5 | 31c6046589e2fbb0486fd044c5b128099d37872f | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 6.78e-05 | 193 | 98 | 5 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.78e-05 | 193 | 98 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 193 | 98 | 5 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 193 | 98 | 5 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.78e-05 | 193 | 98 | 5 | 326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.78e-05 | 193 | 98 | 5 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.78e-05 | 193 | 98 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.78e-05 | 193 | 98 | 5 | 5b84fa640cf30dea55fde53b810f850ff946d253 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-NKT2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.78e-05 | 193 | 98 | 5 | bae37ec161fad7c91edc674a2c7808b51c9a8135 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.95e-05 | 194 | 98 | 5 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.83e-07 | 199 | 97 | 9 | 4687_DN | |
| Drug | Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.96e-06 | 196 | 97 | 8 | 7330_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A | 2.10e-05 | 196 | 97 | 7 | 4547_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A | 2.17e-05 | 197 | 97 | 7 | 4433_UP | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.17e-05 | 197 | 97 | 7 | 4726_DN | |
| Drug | Moxonidine [75438-57-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 2.17e-05 | 197 | 97 | 7 | 7343_UP | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.24e-05 | 198 | 97 | 7 | 6790_DN | |
| Disease | spinocerebellar ataxia type 2 (implicated_via_orthology) | 1.05e-05 | 2 | 96 | 2 | DOID:0050955 (implicated_via_orthology) | |
| Disease | obsolete_interleukin-12 subunit B measurement | 1.18e-05 | 14 | 96 | 3 | EFO_0010787 | |
| Disease | Acute myeloid leukemia | 2.20e-05 | 17 | 96 | 3 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 2.20e-05 | 17 | 96 | 3 | 601626 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.04e-04 | 5 | 96 | 2 | C3281201 | |
| Disease | interleukin-23 measurement | 1.56e-04 | 6 | 96 | 2 | EFO_0020501 | |
| Disease | T-cell immunoglobulin and mucin domain 1 measurement | 2.18e-04 | 7 | 96 | 2 | EFO_0010812 | |
| Disease | vascular cell adhesion protein 1 measurement | 2.18e-04 | 7 | 96 | 2 | EFO_0020846 | |
| Disease | Leukemia, Myelocytic, Acute | 2.60e-04 | 173 | 96 | 5 | C0023467 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 3.72e-04 | 9 | 96 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Acute Promyelocytic Leukemia | 4.58e-04 | 46 | 96 | 3 | C0023487 | |
| Disease | glucagon-like peptide-1 measurement | 4.63e-04 | 10 | 96 | 2 | EFO_0008465 | |
| Disease | mean platelet volume | ARHGAP32 ADAM19 GATA4 FRYL ZMIZ1 BCOR PICALM DCAF5 OTP ATXN2 RIPOR1 | 4.82e-04 | 1020 | 96 | 11 | EFO_0004584 |
| Disease | pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio | 4.88e-04 | 47 | 96 | 3 | EFO_0003892, EFO_0004713, EFO_0005671 | |
| Disease | diastolic blood pressure, alcohol drinking | 6.08e-04 | 118 | 96 | 4 | EFO_0004329, EFO_0006336 | |
| Disease | mean arterial pressure, alcohol consumption measurement | 6.57e-04 | 52 | 96 | 3 | EFO_0006340, EFO_0007878 | |
| Disease | Calcium channel blocker use measurement | 6.71e-04 | 213 | 96 | 5 | EFO_0009930 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 6.77e-04 | 12 | 96 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 6.77e-04 | 12 | 96 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | right ventricular stroke volume measurement | 6.77e-04 | 12 | 96 | 2 | EFO_0021817 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 6.77e-04 | 12 | 96 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 6.95e-04 | 53 | 96 | 3 | C1961099 | |
| Disease | multiple sclerosis | 7.23e-04 | 594 | 96 | 8 | MONDO_0005301 | |
| Disease | cardiovascular disease | 7.44e-04 | 457 | 96 | 7 | EFO_0000319 | |
| Disease | Acute Myeloid Leukemia, M1 | 7.55e-04 | 125 | 96 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 7.55e-04 | 125 | 96 | 4 | C1879321 | |
| Disease | autoimmune thyroid disease | 7.77e-04 | 126 | 96 | 4 | EFO_0006812 | |
| Disease | celiac disease | 7.77e-04 | 126 | 96 | 4 | EFO_0001060 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 7.98e-04 | 13 | 96 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 7.98e-04 | 13 | 96 | 2 | C0265338 | |
| Disease | Genetic chronic primary adrenal insufficiency | 7.98e-04 | 13 | 96 | 2 | Orphanet_101960 | |
| Disease | neutrophil percentage of leukocytes | 8.58e-04 | 610 | 96 | 8 | EFO_0007990 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 9.29e-04 | 14 | 96 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 9.29e-04 | 14 | 96 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | 9.42e-04 | 619 | 96 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | Proteinuria | 1.07e-03 | 15 | 96 | 2 | HP_0000093 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 1.07e-03 | 15 | 96 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | parental longevity | 1.17e-03 | 494 | 96 | 7 | EFO_0007796 | |
| Disease | triacylglycerol 56:9 measurement | 1.38e-03 | 17 | 96 | 2 | EFO_0010436 | |
| Disease | phosphatidylcholine 40:6 measurement | 1.38e-03 | 17 | 96 | 2 | EFO_0010389 | |
| Disease | cortical surface area measurement | MON2 ATXN2L HIPK2 FRYL PICALM FAM168A ATXN2 TJP1 TLE4 KIAA1755 PAX2 FOXG1 | 1.39e-03 | 1345 | 96 | 12 | EFO_0010736 |
| Disease | Feeding difficulties | 1.55e-03 | 18 | 96 | 2 | C0232466 | |
| Disease | prostate cancer (is_marker_for) | 1.71e-03 | 156 | 96 | 4 | DOID:10283 (is_marker_for) | |
| Disease | smoking status measurement, systolic blood pressure | 1.71e-03 | 156 | 96 | 4 | EFO_0006335, EFO_0006527 | |
| Disease | Congenital hernia of foramen of Morgagni | 1.73e-03 | 19 | 96 | 2 | C0265699 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 1.73e-03 | 19 | 96 | 2 | EFO_0002609, GO_0031427 | |
| Disease | Congenital hernia of foramen of Bochdalek | 1.73e-03 | 19 | 96 | 2 | C0265700 | |
| Disease | asthma, endometriosis | 1.83e-03 | 74 | 96 | 3 | EFO_0001065, MONDO_0004979 | |
| Disease | smoking status measurement, diastolic blood pressure | 1.84e-03 | 159 | 96 | 4 | EFO_0006336, EFO_0006527 | |
| Disease | C-reactive protein measurement | ATXN2L ADAM19 RARB MLEC GATA4 ZMIZ1 CYFIP2 UBP1 TLE4 SMARCA4 MERTK | 1.87e-03 | 1206 | 96 | 11 | EFO_0004458 |
| Disease | Craniosynostosis | 1.92e-03 | 20 | 96 | 2 | C0010278 | |
| Disease | alpha-tocopherol measurement | 1.92e-03 | 20 | 96 | 2 | EFO_0007898 | |
| Disease | psoriasis | 2.01e-03 | 273 | 96 | 5 | EFO_0000676 | |
| Disease | Congenital diaphragmatic hernia | 2.11e-03 | 21 | 96 | 2 | C0235833 | |
| Disease | Anophthalmia-microphthalmia syndrome | 2.11e-03 | 21 | 96 | 2 | cv:C5680330 | |
| Disease | diet measurement | STAM2 FLT3 RARB QPCTL GATA4 KHDC4 SMARCA2 SMARCA4 CSMD1 CRTC2 | 2.20e-03 | 1049 | 96 | 10 | EFO_0008111 |
| Disease | anthropometric measurement | 2.24e-03 | 168 | 96 | 4 | EFO_0004302 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 2.29e-03 | 80 | 96 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | nucleus accumbens volume | 2.32e-03 | 22 | 96 | 2 | EFO_0006931 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 2.63e-03 | 84 | 96 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | body weight | ATXN2L HIVEP1 RARB GATA4 HUWE1 USF3 EGR1 LPP MKX PAX2 ARHGAP8 | 2.64e-03 | 1261 | 96 | 11 | EFO_0004338 |
| Disease | airway responsiveness measurement | 2.76e-03 | 24 | 96 | 2 | EFO_0006897 | |
| Disease | Ureteral obstruction | 2.76e-03 | 24 | 96 | 2 | C0041956 | |
| Disease | testosterone measurement | ATXN2L QPCTL GATA4 ZMIZ1 SS18 BIRC6 MGAT5 EGR1 SMARCA2 USH2A LEF1 | 2.88e-03 | 1275 | 96 | 11 | EFO_0004908 |
| Disease | coffee consumption measurement | 2.99e-03 | 182 | 96 | 4 | EFO_0006781 | |
| Disease | eosinophil percentage of leukocytes | 3.02e-03 | 746 | 96 | 8 | EFO_0007991 | |
| Disease | asthma | 3.15e-03 | 751 | 96 | 8 | MONDO_0004979 | |
| Disease | Hashimoto's thyroiditis | 3.24e-03 | 26 | 96 | 2 | EFO_0003779 | |
| Disease | triacylglycerol 48:0 measurement | 3.24e-03 | 26 | 96 | 2 | EFO_0010403 | |
| Disease | maximal oxygen uptake measurement | 3.24e-03 | 26 | 96 | 2 | EFO_0004887 | |
| Disease | platelet component distribution width | 3.25e-03 | 755 | 96 | 8 | EFO_0007984 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MGPPYAGQQELASFH | 296 | P24298 | |
| AKHGPVPSFPSMAYS | 231 | Q5U5X8 | |
| PDPMAQAGFYHQPAS | 306 | Q9NR09 | |
| QNGPYHTSPMIGQFS | 2031 | Q96PZ7 | |
| APGASAYSFPQQHTM | 56 | Q9NY47 | |
| SPHCPTNFYQMDGTP | 491 | Q9H013 | |
| HYFTPGMEPQVPFSD | 656 | Q01954 | |
| MDFLYPNPISTHSGP | 2691 | Q86UQ4 | |
| MGVSPGNPVDSHAYP | 291 | Q6W2J9 | |
| SVAPGFQYHPNLPMH | 1516 | Q9UKL3 | |
| GMEGTPFYQPSPSQD | 736 | Q96KQ4 | |
| PFYQPSPSQDFMGTL | 741 | Q96KQ4 | |
| AHYPSQPVFAPMLQS | 806 | Q8WWM7 | |
| TPPTGHPVQFYSMNR | 341 | Q9NYB9 | |
| AYPQQMHTPPVQSSS | 916 | P49792 | |
| PAVNGHMTHYPATPY | 11 | P10826 | |
| QSHPQEVMYFQPGEP | 306 | Q9NXS2 | |
| MNQPGLVPASTYPHG | 231 | Q9H0J4 | |
| NNDPYMSNGSLSPPI | 121 | Q9UJU2 | |
| MAQAPYSFPHNSPSH | 1066 | Q9H2X6 | |
| QGEDSMSPLYFPQSP | 601 | O60732 | |
| AHPVSMPTYRAQGTP | 221 | Q92567 | |
| DEATMYSNQAFPSPP | 691 | P46934 | |
| LNPQQFYTMFPHTPD | 406 | Q09328 | |
| ASGYQPALMFSPTQP | 56 | Q12866 | |
| PTHNSERPPQGSYMN | 361 | Q5JYT7 | |
| PNPYASDNSSLMFPI | 261 | Q14165 | |
| GLSPNANPAATTHYM | 966 | Q6ZU64 | |
| PSMVGHQQPTPVYTQ | 946 | Q99700 | |
| GSFPHSPTMDNYPKL | 21 | P18146 | |
| YFFPHVPHPSMTSQS | 416 | P55316 | |
| MNGYAEFPPSPSNPT | 1 | O15055 | |
| NPPRTHMNEGGYNTP | 171 | Q8IYA7 | |
| PSAQAPGSSYPPHMQ | 206 | P10515 | |
| PSTGMYHFVINGSIP | 501 | Q6L8Q7 | |
| PVSSGVTHMDNPPYY | 1451 | O94915 | |
| HYPGVPITNFSQMDV | 1446 | Q5H8C1 | |
| YPSAFHSVMFNPVEP | 186 | Q96JK2 | |
| KSAQPSPHYMAAPSS | 226 | Q93052 | |
| LPAPGTTPSDYYHQM | 166 | P10070 | |
| SSLGPPSMPVHYDSQ | 921 | P00451 | |
| PNTGGAAAHPTYHPM | 21 | Q96S07 | |
| PPTIPEGYAMSVAFH | 476 | Q7Z3U7 | |
| PPPSSIMYQANFDTN | 31 | Q96F07 | |
| TGYFSPNDHNVVSMP | 1716 | A7KAX9 | |
| IDPSMDPYPHQFATA | 371 | Q7Z6Z7 | |
| MVPGSEFSGNPYSHP | 361 | Q02962 | |
| PFLTNPNTGDMYTPE | 196 | Q8N6M0 | |
| YPTFQSHPNSSMPGS | 726 | P36888 | |
| FMHGAGAASSPVYVP | 26 | P43694 | |
| YMNPSPFTVSPNTHV | 806 | P51797 | |
| PYPETFHPEVFSMTA | 406 | Q96SD1 | |
| HTSVMNPSPQDTYPG | 176 | Q53ET0 | |
| TPGIMSHVPLYPNSQ | 26 | Q9BY19 | |
| PAVSQKPPFQSGMHY | 216 | Q7Z7F0 | |
| TPTFYDFNPHLGMVP | 636 | Q6UWL6 | |
| ENFPSYNTASTMPPP | 726 | Q9NRM1 | |
| DMYTNGSPAPGSPAQ | 46 | Q00013 | |
| GMEFQYEPHPRTNVP | 1446 | Q9NYC9 | |
| PNPQEFTYSSPTPDM | 441 | Q96LA5 | |
| SHLYQPAFPGMVPAS | 266 | Q5XKR4 | |
| NAMTYPGQPHPALQA | 151 | Q14469 | |
| MFSPSDSEGQLPHYA | 246 | Q10571 | |
| PPMFPNGVIHSYELQ | 4851 | O75445 | |
| AATAPSAMFPYPGQH | 116 | Q16650 | |
| MGPPQSPMDQHSQGY | 106 | P51531 | |
| SSSPARHGEQMPSFY | 96 | Q8N6K7 | |
| PDQKYSMDNTPHTPT | 506 | P10244 | |
| ASQPFSMQPHGVFYE | 476 | Q9BQS7 | |
| SPMDQHSQGYPSPLG | 111 | P51532 | |
| PQTPGTPAMYNTDQF | 876 | O00267 | |
| PSPAMFFQPLYSVHN | 306 | Q01113 | |
| TPSTPQSQHFYQMPT | 551 | Q9UHV7 | |
| QSQHFYQMPTPDPLV | 556 | Q9UHV7 | |
| YLNGVMPPTQSFAPD | 341 | Q9UJM3 | |
| MPHNATYPDSFQQPP | 171 | O15198 | |
| DFMTTNVPNVYPAAP | 96 | P35611 | |
| EMFVGFTPSPVAQPH | 466 | Q13492 | |
| AGSQEPMATFPVPYD | 561 | Q9NUW8 | |
| YSFHVTADGQMQPVP | 446 | Q04724 | |
| YNSSIAGHIPTGFMP | 356 | P50443 | |
| FHVSADGQMQPVPFP | 451 | Q04727 | |
| GGYNHSVPSSQSMPV | 161 | Q15532 | |
| AHYPPASSGVPMQTY | 381 | O75886 | |
| SIPYFPNQMFSNPST | 2126 | Q68DE3 | |
| MAGSHPYLNPPDSTH | 1 | P0C7Q6 | |
| PAYSFHVSADGQMQP | 446 | Q04726 | |
| MAGQDPALSTSHPFY | 1 | P85298 | |
| SGMHHENQTYPPYSP | 886 | Q07157 | |
| HPPFQYVMCAATSPA | 61 | Q9NZI7 | |
| VQTPDPSHPYGFSNM | 291 | Q6PML9 | |
| KFSYPTVPGVMPQHQ | 1246 | Q5JPB2 | |
| FPQSPPAQYSPMHNM | 1476 | Q5TAX3 | |
| NSYTQADPMAPRTPH | 716 | Q6ZS17 | |
| FHVSADGQMQPVPFP | 421 | Q04725 | |
| TQSPPMPIYNSTHVA | 366 | P15822 | |
| AGPPHNEYMEQSFQG | 766 | Q9H1B5 | |
| NGHMPSLPDSPFTGY | 1061 | Q8NFA0 | |
| SPFGTHGQRMPQQTY | 376 | Q9ULJ6 | |
| FPNSNSMYIDRPPSG | 166 | Q13094 |